Effects of granulocyte colony-stimulating factor on the development of inflammation in bleomycin-induced lung injury

Journal of Toxicologic Pathology

Volumn 14, Issue 4, 2001, Pages 289-297

  Adachi, Kenji ^a,b   Suzuki, Masami ^a   Sugimoto, Tetsurou ^a   Uetsuka, Koji ^b   Nakayama, Hiroyuki ^b   Doi, Kunio ^b  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bleomycin; Diffuse alveolar damage; Granulocyte colony stimulating factor; Inflammatory phase; Neutrophil; Pulmonary fibrosis

Indexed keywords

EID: 0042185342     PISSN: 09149198     EISSN: 09149198     Source Type: Journal    
DOI: 10.1293/tox.14.289     Document Type: Article

References (32)

1. Demetri GD, and Griffin JD. Granulocyle colony-stimulating factor and its receptor. Blood 1991; 78: 2791-2808.
2. Welt K, Bonilla MA, Gabrilove JL, Gillio AP, Potter GK, Moore MAS, O'reilly RJ, Boone TC, and Souza LM. Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesis. Blood Cells 1987; 13: 17-30.
3. Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, and Dexter TM. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 1987; 56: 809-813.
4. Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M, Sheridan W, and Metcalf D. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1: 667-671.
5. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MAS, Clarkson B, Oettgen HF, Alton K, Welte K, and Souza L. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988; 318: 1414-1422.
6. Gabrilove JL, Jakubowski A, Fain K, Grous J, Scher H, Sternberg C, Yagoda A, Clarkson B, Bonilla MA, Oettgen HF, Alton K, Boone T, Altrock B, Welte K, and Souza L. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 1988; 82: 1454-1461.
7. Iki S, Yoshinaga K, Ohbayashi Y, and Urabe A. Cytotoxic drug-induced pneumonia and possible augmentation by G-CSF - clinical attention. Ann Hematol 1993; 66: 217-218.
8. Katoh M, Shikoshi K, Takada M, Umeda M, Tsukahara T, Kitagawa S, and Shirai T. Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor. Ann Hematol 1993; 67: 201-202.
9. Matthews JH. Pulmonary toxicity of ABVD chemotherapy and G-CSF in Hodgkin's diseases: possible synergy. Lancet 1993;342:988.
10. Dirix LY, Schrijvers D, Druwè P, Brande JVD, Verhoeven D, and Oosterom ATV. Pulmonary toxicity and bleomycin. Lancet 1994; 344: 56.
11. Niitsu N, Iki S, Muroi K, Motomura S, Murakami M, Takeyama H, Ohsaka A, and Urabe A. Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991-96. Br J Cancer 1997; 76: 1661-1666.
12. Couderc LJ, Stelianides S, Frachon I, Stern M, Epardeau B, Baumelou E, Caubarrere I, and Hermine O. Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases. Respir Med 1999; 93: 65-68.
13. Eisenbeis CF, Winn D, Poelman S, Polsky CV, Rubenstein JH, and Olopade OI. A case of pulmonary toxicity associated with G-CSF and doxorubicin administration. Ann Hematol 2001; 80: 121-123.
14. Tale RM, and Repine JE. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 1983; 128: 552-559.
15. Kanazawa M, Ishizaka A, Hasegawa N, Suzuki Y, and Yokoyama T. Granulocyte colony-stimulating factor dose not enhance endotoxin-induced acute lung injury in guinea pigs. Am Rev Respir Dis 1992; 145: 1030-1035.
16. Koizumi T, Kubo K, Shinozaki S, Koyama S, Kobayashi T, and Sekiguchi M. Granulocyte colony-stimulating factor dose not exacerbate endotoxin-induced lung injury in sheep. Am Rev Respir Dis 1993; 148: 132-137.
17. Terashima T, Kanazawa M, Sayama K, Ishizaka A, Urano T, Sakamaki F, Nakamura H, Waki Y, and Tasaka S. Granulocyte colony-stimulating factor exacerbates acute lung injury induced by intratracheal endotoxin in guinea pigs. Am J Respir Crit Care Med 1994; 149: 1295-1303.
18. King J, Deboisblanc BP, Mason CM, Onofrio JM, Lipscomb G, Mercante DE, Summer WR, and Nelson S. Effect of granulocyte colony-stimulating factor on acute lung injury in rat. Am J Respir Crit Care Med 1995; 151: 302-309.
19. Koizumi T, Kubo K, Koyama S, Hanaoka M, Hayano T, Miyahara T, Kobayashi T, and Sekiguchi M. Neutrophils pretreated with granulocyte colony-stimulating factor (G-CSF) are not related to the severity of endotoxin-induced lung injury. Exp Lung Res 1997; 23: 393-404.
20. Yara S, Kawakami K, Kudeken N, Tohyama M, Teruya K, Chinen T, Awaya A, and Saito A. FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice. Clin Exp Immunol 2001; 124: 77-85.
21. Adachi K, Suzuki M, Sugimoto T, Suzuki S, Niki R, Oyama A, Uetsuka K, Nakayama H, and Doi K. Granulocyte colony-stimulating factor exacerbates the acute lung injury and pulmonary fibrosis induced by intratracheal administration of bleomycin in rats. Exp Toxic Pathol (in press).
22. Mautz WJ, Kleinman MT, Phalen RF, and Crocker TT. Effects of exercise exposure on toxic interactions between inhaled oxidant and aldehyde air pollutants. J Toxicol Environ Health 1988; 25: 165-177.
23. Ashcroft T, Simpson JM, and Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988; 41: 467-470.
24. Lazenby AJ, Crouch EC, McDonald JA, and Kuhn III C. Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat - an immunohistochemical study of laminin, type IV collagen, and fibronectin. Am Rev Respir Dis 1990; 142: 206-214.
25. Kawamoto M, and Fukuda Y. Cell proliferation during the process of bleomycin-induced pulmonary fibrosis in rats. Acta Pathol Jpn 1990; 40: 227-238.
26. Usuki J, and Fukuda Y. Evolution of three patterns of intraalveolar fibrosis produced by bleomycin in rats. Pathol Int 1995; 45: 552-564.
27. Thrall RS, McCormick JR, Jack RM, McReynolds RA, and Ward PA. Bleomycin-induced pulmonary fibrosis in the rat - inhibition by indomethacin. Am J Pathol 1979; 95: 117-130.
28. Lindenschmidt RC, Tryka AF, Godfrey GA, Frome EL, and Witschi H. Intratracheal versus intravenous administration of bleomycin in mice: acute effects. Toxicol Appl Pharmacol 1986; 85: 69-77.
29. Fukuda Y, Ishizaki M, Masuda Y, Kimura G, Kawanami O, and Masugi Y. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol 1987; 126: 171-182.
30. Hierholzer C, Kelly E, Lyons V, Roedling E, Davies P, Billiar TR, and Tweardy DJ. G-CSF instillation into rat lungs mediates neutrophil recruitment, pulmonary edema, and hypoxia. J Leukoc Biol 1998; 63: 169-174.
31. Thrall RS, Phan SH, McCormick JR, and Ward PA. The development of bleomycin-induced pulmonary fibrosis in neutrophil depleted and complement-depleted rats. Am J Pathol 1981; 105: 76-81.
32. Clark JG, and Kuhn C. Bleomycin-induced pulmonary fibrosis in hamsters: effect of neutrophil depletion on lung collagen synthesis. Am Rev Respir Dis 1982; 126: 737-739.